Daktronics, Inc. (NASDAQ: DAKT) is a sell, thinks Cramer.
Cramer would cut losses in TherapeuticsMD Inc (NASDAQ: TXMD).
Canopy Growth Corp (NYSE: CGC) is the only one in the sector Cramer is recommending.
Cramer is a seller of Rite Aid Corporation (NYSE: RAD).
Genpact Limited (NYSE: G) has moved up a lot, but it is a great story, said Cramer.
Cramer would stay away from California Water Service Group (NYSE: CWT). He doesn't want anything to do with California and regulation whatsoever.
Dermira Inc (NASDAQ: DERM) is a nice spec, said Cramer. Dermatology is an okay business, not great, thinks Cramer.
See more from Benzinga
- Jim Cramer Weighs In On CVS, Starbucks, Tilray And More
- Canopy Growth, Lockheed Martin, Merck And More: 'Fast Money Halftime Report' Picks For May 3
- Jim Cramer Weighs In On Canopy Growth, Levi, Twilio And More
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.